DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Chan AW, Moliterno DJ, Berger PB. , et al; TARGET Investigators.
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).

J Am Coll Cardiol 2003;
42 (07) 1188-1195

Download Bibliographical Data

Search in:
Access:
Access: